Skip to main content

Advertisement

Log in

Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA

  • Brief Communication
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the reliability of the autoimmune bullous diseases quality of life (ABQOL) questionnaire in a North American patient cohort.

Methods

Patients attending the dermatology clinics of the University of Pennsylvania with a histological diagnosis of an autoimmune bullous disease (AIBD) and self-reported proficiency in English were recruited to participate in the study. Patients completed the ABQOL questionnaire at Day 0 and Day 3. Internal consistency was calculated through Cronbach’s alpha. Test–retest reliability was determined by the intraclass correlation coefficient.

Results

Of the 45 patients enrolled in the study, 39 patients (87 %) participated to completion. The mean age was 60.7 years with an equal sex distribution observed. Patients had a range of AIBD including pemphigus vulgaris, bullous pemphigoid, pemphigus foliaceus, epidermolysis bullosa acquisita, mucous membrane pemphigoid and linear IgA disease. Cronbach’s alpha was calculated to be 0.90. The intraclass correlation coefficient was calculated to be 0.93 (95 % confidence interval 0.88–0.94).

Conclusion

The ABQOL was found to be reliable tested by internal consistency and test–retest reliability in an American patient cohort. It represents a promising disease-specific outcome measure for patients with AIBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Sebaratnam, D. F., McMillan, J. W., Werth, V. P., & Murrell, D. F. (2012). Quality of life in patients with bullous dermatoses. Clinics in Dermatology, 30(1), 103–107.

    Article  PubMed  Google Scholar 

  2. Chen, S. (2007). Dermatology quality of life instruments: Sorting out the quagmire. Journal of Investigative Dermatology, 127(12), 2695–2696.

    Article  CAS  PubMed  Google Scholar 

  3. Sebaratnam, D. F., Hanna, A. M., Chee, S. N., et al. (2013). Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire. JAMA Dermatology, 149(1), 1186–1191.

    Article  PubMed  Google Scholar 

  4. Karpouzis, A., Vamvassakis, E., Stavrianeas, N., et al. (2002). Ultrastructural immunocytochemistry of autoimmune bullous diseases. Australasian Journal of Dermatology, 43(2), 113–119.

    Article  PubMed  Google Scholar 

  5. Sebaratnam, D. F., & Murrell, D. F. (2009). Treatment of pemphigus vulgaris and pemphigus foliaceus. Expert Review of Dermatology, 4(5), 469–481.

    Article  CAS  Google Scholar 

  6. Grob, J. J. (2007). Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? Journal of Investigative Dermatology, 127(10), 2299–2301.

    Article  CAS  PubMed  Google Scholar 

  7. Prinsen, C. A. C., de Korte, J., Augustin, M., et al. (2013). Measurement of health-related quality of life in dermatological research and practice: Outcome of the EADV taskforce on quality of life. Journal of the European Academy of Dermatology and Venereology, 27(10), 1195–1203.

    CAS  PubMed  Google Scholar 

  8. Rosenbach, M., Murrell, D. F., Bystryn, J. C., et al. (2009). Reliability and convergent validity of two outcome instruments for pemphigus. Journal of Investigative Dermatology, 129(10), 2404–2410.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Clemens, S., Begum, N., Harper, C., et al. (2014). A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Quality of Life Research, 23(8), 2375–2381.

    Article  PubMed  Google Scholar 

  10. Sebaratnam, D. F., Frew, J. W., Davatchi, F., et al. (2012). Quality-of-life measurement in blistering diseases. Dermatologic Clinics, 30(2), 301–307.

    Article  CAS  PubMed  Google Scholar 

  11. Martin, L. K., Werth, V. P., Villaneuva, E. V., et al. (2011). A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. Journal of the American Academy of Dermatology, 64(5), 903–908.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are indebted to the Medical Dermatology Society for awarding Deshan Sebaratnam a mentorship with Victoria Werth to complete this research and a poster prize at the Medical Dermatology Society Annual Meeting 2014; and to John Stanley, Ioannis Koutroulis and Nicole Fett for their assistance with patient recruitment. This material is supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development).

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Victoria P. Werth.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sebaratnam, D.F., Okawa, J., Payne, A. et al. Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA. Qual Life Res 24, 2257–2260 (2015). https://doi.org/10.1007/s11136-015-0965-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-015-0965-z

Keywords

Navigation